Inspire Medical Systems, Inc.
INSP · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $224,501 | $217,086 | $201,317 | $239,718 |
| % Growth | 3.4% | 7.8% | -16% | – |
| Cost of Goods Sold | $31,773 | $34,672 | $30,709 | $35,988 |
| Gross Profit | $192,728 | $182,414 | $170,608 | $203,730 |
| % Margin | 85.8% | 84% | 84.7% | 85% |
| R&D Expenses | $24,211 | $26,209 | $27,803 | $30,336 |
| G&A Expenses | $122,464 | $134,821 | $0 | $0 |
| SG&A Expenses | $158,873 | $159,521 | $144,290 | $141,510 |
| Sales & Mktg Exp. | $36,409 | $24,700 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $183,084 | $185,730 | $172,093 | $171,846 |
| Operating Income | $9,644 | -$3,316 | -$1,485 | $31,884 |
| % Margin | 4.3% | -1.5% | -0.7% | 13.3% |
| Other Income/Exp. Net | $3,907 | $984 | $5,644 | $4,752 |
| Pre-Tax Income | $13,551 | -$2,332 | $4,159 | $36,636 |
| Tax Expense | $3,619 | $1,260 | $1,167 | $1,412 |
| Net Income | $9,932 | -$3,592 | $2,992 | $35,224 |
| % Margin | 4.4% | -1.7% | 1.5% | 14.7% |
| EPS | 0.34 | -0.12 | 0.1 | 1.18 |
| % Growth | 383.3% | -220% | -91.5% | – |
| EPS Diluted | 0.34 | -0.12 | 0.1 | 1.15 |
| Weighted Avg Shares Out | 29,332 | 29,507 | 29,702 | 29,828 |
| Weighted Avg Shares Out Dil | 29,600 | 29,507 | 30,311 | 30,751 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3,973 | $4,486 | $5,066 | $5,552 |
| Interest Expense | $0 | $4 | $0 | $0 |
| Depreciation & Amortization | $3,677 | $3,414 | $3,044 | $2,478 |
| EBITDA | $17,228 | $1,086 | $1,559 | $56,754 |
| % Margin | 7.7% | 0.5% | 0.8% | 23.7% |